Business
BullFrog AI’s Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar
GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that Dr. Juan Felipe Beltrán, Director of AI, Machine Learning, and Innovation, will be the featured speaker at the upcoming XTalks webinar: AI in Bioinformatics: Overcoming P
About this update from Bullfrog Ai Holdings, Inc.
[{"type":"image","alt":"BullFrog AI Holdings, Inc.","displaySize":"","headline":null,"caption":"BullFrog AI Holdings, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":73,"url":"https://media.zenfs.com/en/globenewswire.com/40a6d1d7288dd7624185c5755b024c0e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cckXAhHY1jCBABonzk6CjQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/40a6d1d7288dd7624185c5755b024c0e","width":300,"height":73}},"lazy":false},{"type":"text","content":"GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that Dr. Juan Felipe Beltrán, Director of AI, Machine Learning, and Innovation, will be the featured speaker at the upcoming XTalks webinar: AI in Bioinformatics: Overcoming Pitfalls in Statistical, ML and Generative AI Approaches.","length":581,"tagName":"p"},{"type":"text","content":"Vin Singh, Founder and CEO of BullFrog AI, commented, "Dr. Beltrán’s featured participation in the XTalks webinar not only highlights our leadership position in AI-driven bioinformatics but also emphasizes BullFrog AI’s dedication to addressing critical scientific challenges that directly impact the efficiency and success of drug development pipelines. Investors recognize the significant market opportunity in enhancing drug discovery processes, and showcasing BullFrog AI’s innovative capabilities supports our strategic vision and fortifies our position within this rapidly growing sector."","length":605,"tagName":"p"},{"type":"text","content":"Join Dr. Juan Felipe Beltrán, a leading scientist and software engineer with deep expertise in machine learning, algorithm development, and bioinformatics, for an insightful webinar exploring the critical yet often overlooked pitfalls in AI-driven bioinformatics workflows. Drawing on his extensive contributions to proteomics, genomics, and public health challenges like COVID-19, Dr. Beltrán will highlight how even sophisticated computational methods can falter without careful attention to analytical nuance.","length":512,"ta...